Multifactorial nature of human immunodeficiency virus disease: implications for therapy
- PMID: 8235617
- DOI: 10.1126/science.8235617
Multifactorial nature of human immunodeficiency virus disease: implications for therapy
Abstract
The immunopathogenic mechanisms underlying human immunodeficiency virus (HIV) disease are extremely complex; the disease process is multifactorial with multiple overlapping phases. Viral burden is substantial and viral replication occurs throughout the entire course of HIV infection. Inappropriate immune activation and elevated secretion of certain cytokines compound the pathogenic process. Profound immunosuppression ultimately occurs together with a disruption of the microenvironment of the immune system, which is probably unable to regenerate spontaneously. Thus, therapeutic strategies in HIV disease must not be unidimensional, but rather must be linked to the complex pathogenic components of the disease and must address where feasible each of the recognized pathogenic processes for the possibility of therapeutic intervention.
Similar articles
-
Challenges in the therapy of HIV infection.Trends Pharmacol Sci. 1993 May;14(5):196-202. doi: 10.1016/0165-6147(93)90208-2. Trends Pharmacol Sci. 1993. PMID: 8212316 Review.
-
Challenges in the therapy of HIV infection.Immunol Today. 1993 Jun;14(6):303-9. doi: 10.1016/0167-5699(93)90050-U. Immunol Today. 1993. PMID: 8397771 Review.
-
AIDS pathogenesis: mathematical models of HIV and SIV infections.AIDS. 1993;7 Suppl 1:S3-18. AIDS. 1993. PMID: 8363800 Review. No abstract available.
-
Regulation of HIV replication in monocytes by interferon.Prog Mol Subcell Biol. 1994;14:222-41. doi: 10.1007/978-3-642-78549-8_13. Prog Mol Subcell Biol. 1994. PMID: 7520329 Review. No abstract available.
-
Role of lymphoid organs in the pathogenesis of human immunodeficiency virus (HIV) infection.Immunol Rev. 1994 Aug;140:105-30. doi: 10.1111/j.1600-065x.1994.tb00867.x. Immunol Rev. 1994. PMID: 7821924 Review.
Cited by
-
Treatment of intestinal helminths does not reduce plasma concentrations of HIV-1 RNA in coinfected Zambian adults.J Infect Dis. 2005 Oct 1;192(7):1277-83. doi: 10.1086/444543. Epub 2005 Aug 25. J Infect Dis. 2005. PMID: 16136473 Free PMC article. Clinical Trial.
-
The Role of the Envelope Glycoprotein in the Depletion of T Helper Cells in Human Immunodeficiency Virus Infection.Pathol Oncol Res. 1997;3(1):62-67. doi: 10.1007/BF02893356. Pathol Oncol Res. 1997. PMID: 11173628
-
Increased Mycobacterium tuberculosis growth in HIV-1-infected human macrophages: role of tumour necrosis factor-alpha.Clin Exp Immunol. 2001 Mar;123(3):435-42. doi: 10.1046/j.1365-2249.2001.01481.x. Clin Exp Immunol. 2001. PMID: 11298131 Free PMC article.
-
T helper type 1/T helper type 2 cytokines and T cell death: preventive effect of interleukin 12 on activation-induced and CD95 (FAS/APO-1)-mediated apoptosis of CD4+ T cells from human immunodeficiency virus-infected persons.J Exp Med. 1995 Dec 1;182(6):1759-67. doi: 10.1084/jem.182.6.1759. J Exp Med. 1995. PMID: 7500020 Free PMC article.
-
Multisite comparison of high-sensitivity multiplex cytokine assays.Clin Vaccine Immunol. 2011 Aug;18(8):1229-42. doi: 10.1128/CVI.05032-11. Epub 2011 Jun 22. Clin Vaccine Immunol. 2011. PMID: 21697338 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
